MIM
JSPRW icon

Monashee Investment Management’s Japer Therapeutics Warrants JSPRW Stock Holding History

Monashee Investment Management’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-87,500
Closed -$101K – 319
2021
Q2 		$101K Hold
87,500
– – 0.01% 319
2021
Q1 		$72K Hold
87,500
– – 0.01% 315
2020
Q4 		$127K Hold
87,500
– – 0.02% 241
2020
Q3 		$103K Hold
87,500
– – 0.02% 147
2020
Q2 		$88K Hold
87,500
– – 0.01% 175
2020
Q1 		$57K Buy
+87,500
New +$68.7K 0.03% 39

Other funds holding JSPRW

OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
ZA
Zazove Associates Incline Village, Nevada $1.22B AUM 1.91% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.55% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Monashee Investment Management's JSPRW Position: Q3 2021 in Review

Monashee Investment Management sold out of Japer Therapeutics Warrants (JSPRW) in Q3 2021, closing a stake of 87,500 shares — an estimated $101K sold.

Monashee Investment Management first reported a position in JSPRW in Q1 2020 and held it in 6 quarters. The position peaked at $127K in Q4 2020. 16 funds tracked by Wall St. Rank hold JSPRW as of Q3 2021.

  • Monashee Investment Management reported no remaining Japer Therapeutics Warrants position as of Q3 2021 after selling out during the quarter.
  • Monashee Investment Management sold 87,500 Japer Therapeutics Warrants shares in Q3 2021, an estimated $101K.
  • Monashee Investment Management first reported a position in Japer Therapeutics Warrants in Q1 2020 and held it in 6 quarters.
  • Monashee Investment Management's Japer Therapeutics Warrants position peaked at $127K in Q4 2020.
  • 16 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q3 2021.

Based on Monashee Investment Management's 13F filing for Q3 2021, filed 9 Nov 2021.